Ledger.Open graph →

SEC Form D · Amendment · filed November 3, 2011

NGM BIOPHARMACEUTICALS INC

Offering

$55.7M

Sold

$38.5M

Exemption

—

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

People & firms on this filing (16)

Ravi Mohan · Menlo Park, CADirector Robert Pinnick · Bend, ORExec Elliott Elbaz · Mill Valley, CADirector Michael Hormaechea · Boise, IDExec · Director James J. Lynch · HARTFORD, CTExec · Director Frank G. Mazzola · New York, NYDirector Steven J. Kapiloff · HARTFORD, CTExec · Director Arthur D. Levinson · South San Francisco, CADirector Gail Naughton · Encinitas, CADirector Rajan Sobhani · Plano, TXDirector Michael Phippen · Mill Valley, CAExec · Director Peter Svennilson · Gulf Stream, FLDirector Jane Boutelle · Madison, WIExec · Director Marc Leschly · Palo Alto, CADirector Monika Wingate · Madison, WIExec · Director Helen Kim · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗